Approval · Notice of Compliance 34928 · 2025
QALSODY: Notice of Compliance 34928
Issued February 28, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 34928
- Date
- February 28, 2025
- Company
- Biogen Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- With conditions
- Yes (NOC/c)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| QALSODY | 02555735 | Marketed |
Medicinal ingredients
- TOFERSEN 100 MG per 15ML